Blue-chip stocks have always been the bedrock of stable, trustworthy investments. These goliaths of the stock market have proven themselves as invaluable assets over the years.
APPLE (AAPL)
Source: Eric Broder Van Dyke / Shutterstock.com
The first pick is the illustrious Apple (NASDAQ:AAPL). The legendary corporation, wealthiest of them all, has been churning out revenue with the tenacity of a heavyweight boxer. Warren Buffett has been singing praises about Apple, and for good reason. Despite a dip in sales from the Chinese market, Apple has proven to be a resilient force, bouncing back with sales exceeding $70 billion in 2021 and 2022 after the pandemic-induced downturn.
With a price-to-earnings (P/E) ratio below the sector average and a market cap of $2.8 trillion, Apple has consistently surpassed analysts’ quarterly EPS expectations. Additionally, the company offers a modest dividend yield of 0.52%.
Anheuser-Busch InBev (BUD)
Source: Michael Vi / Shutterstock.com
Next on the list is the mighty AB InBev (NYSE:BUD). As the largest brewer in the U.S. and worldwide, AB InBev has stood its ground amid economic turmoil. Even after last year’s marketing fiasco with Bud Light, the company has returned to a position of strength. With a P/E ratio below the industry average and a generous forward dividend, AB InBev is an enticing choice for long-term investors.
Johnson & Johnson (JNJ)
Source: Alexander Tolstykh / Shutterstock.com
Lastly, we have the venerable Johnson & Johnson (NYSE:JNJ). Having recently divested its consumer products division, JNJ has shifted its focus squarely on healthcare. With a diversified product pipeline and a strong financial standing, JNJ stands at a P/E ratio of 30x and offers a commendable dividend yield of 3.1%.
For those considering the long haul, these three blue-chip stocks represent a rock-solid opportunity. As the clouds of market uncertainty loom overhead with potential economic turmoil, these stocks could provide the much-needed ballast for your portfolio.
On the date of publication, Stavros Tousios did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
